GMI Research

In Vivo Bioreactor is a new approach to regenerate autologous fabricated tissue flaps or bone tissue and transplant it into ectopic site in patient’s body. In Vivo Bioreactor is a revolution for aesthetic reconstruction. Bioreactors are basically similar to external chambers in which biotic tissues can be grown. In Vivo bioreactors can generate fabricated tissues inside human body in natural way without contribution of exogenous elements. The major driving factor of In Vivo Bioreactor market is adoption of Single-use-bioreactors. Technology upgradation is also helped to grow the In Vivo Bioreactor market. Single-use-bioreactors use disposable bag instead of cultural vessel that increase the efficiency of bioreactors in terms of quality control and procurement. In Vivo Bioreactors minimize the donor side morbidity that decrease the exogenous complexity. Another driving factors of this market are: increasing organ transplantations, growing cell-based research market and biologic ma...